 | • レポートコード：MRC2-11QY04326 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はポンペ病治療のグローバル市場について調査・分析したレポートです。種類別（乳児期発症ポンペ病、成人発症ポンペ病）市場規模、用途別（病院、医療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ポンペ病治療の競争状況、市場シェア ・世界のポンペ病治療市場：種類別市場規模 2015年-2020年（乳児期発症ポンペ病、成人発症ポンペ病） ・世界のポンペ病治療市場：種類別市場規模予測 2021年-2026年（乳児期発症ポンペ病、成人発症ポンペ病） ・世界のポンペ病治療市場：用途別市場規模 2015年-2020年（病院、医療センター、その他） ・世界のポンペ病治療市場：用途別市場規模予測 2021年-2026年（病院、医療センター、その他） ・北米のポンペ病治療市場分析：米国、カナダ ・ヨーロッパのポンペ病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのポンペ病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のポンペ病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのポンペ病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amicus Therapeutics、Audentes Therapeutics、Sanofi Genzyme、EpiVax、Oxyrane、Sangamo BioSciences、Valerion Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pompe disease is a rare disease, also known as acid maltase deficiency (AMD) or glycogen storage disorder (GSD).Glycogenosis II is also called “glycogenosis type 2”.
The availability of reimbursement policies for the treatment Pompe disease as one of the primary factors that will have a positive impact on the growth of this market.
Market Analysis and Insights: Global Pompe Disease Treatment Market
The global Pompe Disease Treatment market size is projected to reach US$ 966.5 million by 2026, from US$ 945.2 million in 2020, at a CAGR of 2.1%% during 2021-2026.
Global Pompe Disease Treatment Scope and Market Size
Pompe Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pompe Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Amicus Therapeutics
Audentes Therapeutics
Sanofi Genzyme
EpiVax
Oxyrane
Sangamo BioSciences
Valerion Therapeutics
…
Market segment by Type, the product can be split into
Infantile-Onset Pompe Disease
Adult-Onset Pompe Disease
Market segment by Application, split into
Hospital
Medical Center
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pompe Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Pompe Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Infantile-Onset Pompe Disease
1.4.3 Adult-Onset Pompe Disease
1.5 Market by Application
1.5.1 Global Pompe Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Medical Center
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pompe Disease Treatment Market Perspective (2015-2026)
2.2 Global Pompe Disease Treatment Growth Trends by Regions
2.2.1 Pompe Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pompe Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Pompe Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pompe Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Pompe Disease Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pompe Disease Treatment Players by Market Size
3.1.1 Global Top Pompe Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Pompe Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Pompe Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pompe Disease Treatment Market Concentration Ratio
3.2.1 Global Pompe Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pompe Disease Treatment Revenue in 2019
3.3 Pompe Disease Treatment Key Players Head office and Area Served
3.4 Key Players Pompe Disease Treatment Product Solution and Service
3.5 Date of Enter into Pompe Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pompe Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Pompe Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pompe Disease Treatment Market Size by Application (2015-2020)
5.2 Global Pompe Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pompe Disease Treatment Market Size (2015-2020)
6.2 Pompe Disease Treatment Key Players in North America (2019-2020)
6.3 North America Pompe Disease Treatment Market Size by Type (2015-2020)
6.4 North America Pompe Disease Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pompe Disease Treatment Market Size (2015-2020)
7.2 Pompe Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Pompe Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Pompe Disease Treatment Market Size by Application (2015-2020)
8 China
8.1 China Pompe Disease Treatment Market Size (2015-2020)
8.2 Pompe Disease Treatment Key Players in China (2019-2020)
8.3 China Pompe Disease Treatment Market Size by Type (2015-2020)
8.4 China Pompe Disease Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pompe Disease Treatment Market Size (2015-2020)
9.2 Pompe Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Pompe Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Pompe Disease Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pompe Disease Treatment Market Size (2015-2020)
10.2 Pompe Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pompe Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Pompe Disease Treatment Market Size by Application (2015-2020)
11 India
11.1 India Pompe Disease Treatment Market Size (2015-2020)
11.2 Pompe Disease Treatment Key Players in India (2019-2020)
11.3 India Pompe Disease Treatment Market Size by Type (2015-2020)
11.4 India Pompe Disease Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pompe Disease Treatment Market Size (2015-2020)
12.2 Pompe Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Pompe Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Pompe Disease Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Amicus Therapeutics
13.1.1 Amicus Therapeutics Company Details
13.1.2 Amicus Therapeutics Business Overview
13.1.3 Amicus Therapeutics Pompe Disease Treatment Introduction
13.1.4 Amicus Therapeutics Revenue in Pompe Disease Treatment Business (2015-2020))
13.1.5 Amicus Therapeutics Recent Development
13.2 Audentes Therapeutics
13.2.1 Audentes Therapeutics Company Details
13.2.2 Audentes Therapeutics Business Overview
13.2.3 Audentes Therapeutics Pompe Disease Treatment Introduction
13.2.4 Audentes Therapeutics Revenue in Pompe Disease Treatment Business (2015-2020)
13.2.5 Audentes Therapeutics Recent Development
13.3 Sanofi Genzyme
13.3.1 Sanofi Genzyme Company Details
13.3.2 Sanofi Genzyme Business Overview
13.3.3 Sanofi Genzyme Pompe Disease Treatment Introduction
13.3.4 Sanofi Genzyme Revenue in Pompe Disease Treatment Business (2015-2020)
13.3.5 Sanofi Genzyme Recent Development
13.4 EpiVax
13.4.1 EpiVax Company Details
13.4.2 EpiVax Business Overview
13.4.3 EpiVax Pompe Disease Treatment Introduction
13.4.4 EpiVax Revenue in Pompe Disease Treatment Business (2015-2020)
13.4.5 EpiVax Recent Development
13.5 Oxyrane
13.5.1 Oxyrane Company Details
13.5.2 Oxyrane Business Overview
13.5.3 Oxyrane Pompe Disease Treatment Introduction
13.5.4 Oxyrane Revenue in Pompe Disease Treatment Business (2015-2020)
13.5.5 Oxyrane Recent Development
13.6 Sangamo BioSciences
13.6.1 Sangamo BioSciences Company Details
13.6.2 Sangamo BioSciences Business Overview
13.6.3 Sangamo BioSciences Pompe Disease Treatment Introduction
13.6.4 Sangamo BioSciences Revenue in Pompe Disease Treatment Business (2015-2020)
13.6.5 Sangamo BioSciences Recent Development
13.7 Valerion Therapeutics
13.7.1 Valerion Therapeutics Company Details
13.7.2 Valerion Therapeutics Business Overview
13.7.3 Valerion Therapeutics Pompe Disease Treatment Introduction
13.7.4 Valerion Therapeutics Revenue in Pompe Disease Treatment Business (2015-2020)
13.7.5 Valerion Therapeutics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pompe Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Pompe Disease Treatment Revenue
Table 3. Ranking of Global Top Pompe Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pompe Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Infantile-Onset Pompe Disease
Table 6. Key Players of Adult-Onset Pompe Disease
Table 7. Global Pompe Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Pompe Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Pompe Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Pompe Disease Treatment Market Share by Regions (2015-2020)
Table 11. Global Pompe Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Pompe Disease Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Pompe Disease Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Pompe Disease Treatment Players
Table 18. Global Pompe Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Pompe Disease Treatment Market Share by Players (2015-2020)
Table 20. Global Top Pompe Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pompe Disease Treatment as of 2019)
Table 21. Global Pompe Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pompe Disease Treatment Product Solution and Service
Table 24. Date of Enter into Pompe Disease Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pompe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Pompe Disease Treatment Market Size Share by Type (2015-2020)
Table 28. Global Pompe Disease Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Pompe Disease Treatment Market Size Share by Application (2015-2020)
Table 30. Global Pompe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Pompe Disease Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Pompe Disease Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Pompe Disease Treatment Market Share (2019-2020)
Table 34. North America Pompe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Pompe Disease Treatment Market Share by Type (2015-2020)
Table 36. North America Pompe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Pompe Disease Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Pompe Disease Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Pompe Disease Treatment Market Share (2019-2020)
Table 40. Europe Pompe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Pompe Disease Treatment Market Share by Type (2015-2020)
Table 42. Europe Pompe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Pompe Disease Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Pompe Disease Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Pompe Disease Treatment Market Share (2019-2020)
Table 46. China Pompe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Pompe Disease Treatment Market Share by Type (2015-2020)
Table 48. China Pompe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Pompe Disease Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Pompe Disease Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Pompe Disease Treatment Market Share (2019-2020)
Table 52. Japan Pompe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Pompe Disease Treatment Market Share by Type (2015-2020)
Table 54. Japan Pompe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Pompe Disease Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Pompe Disease Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Pompe Disease Treatment Market Share (2019-2020)
Table 58. Southeast Asia Pompe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Pompe Disease Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Pompe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Pompe Disease Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Pompe Disease Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Pompe Disease Treatment Market Share (2019-2020)
Table 64. India Pompe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Pompe Disease Treatment Market Share by Type (2015-2020)
Table 66. India Pompe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Pompe Disease Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Pompe Disease Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Pompe Disease Treatment Market Share (2019-2020)
Table 70. Central & South America Pompe Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Pompe Disease Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Pompe Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Pompe Disease Treatment Market Share by Application (2015-2020)
Table 74. Amicus Therapeutics Company Details
Table 75. Amicus Therapeutics Business Overview
Table 76. Amicus Therapeutics Product
Table 77. Amicus Therapeutics Revenue in Pompe Disease Treatment Business (2015-2020) (Million US$)
Table 78. Amicus Therapeutics Recent Development
Table 79. Audentes Therapeutics Company Details
Table 80. Audentes Therapeutics Business Overview
Table 81. Audentes Therapeutics Product
Table 82. Audentes Therapeutics Revenue in Pompe Disease Treatment Business (2015-2020) (Million US$)
Table 83. Audentes Therapeutics Recent Development
Table 84. Sanofi Genzyme Company Details
Table 85. Sanofi Genzyme Business Overview
Table 86. Sanofi Genzyme Product
Table 87. Sanofi Genzyme Revenue in Pompe Disease Treatment Business (2015-2020) (Million US$)
Table 88. Sanofi Genzyme Recent Development
Table 89. EpiVax Company Details
Table 90. EpiVax Business Overview
Table 91. EpiVax Product
Table 92. EpiVax Revenue in Pompe Disease Treatment Business (2015-2020) (Million US$)
Table 93. EpiVax Recent Development
Table 94. Oxyrane Company Details
Table 95. Oxyrane Business Overview
Table 96. Oxyrane Product
Table 97. Oxyrane Revenue in Pompe Disease Treatment Business (2015-2020) (Million US$)
Table 98. Oxyrane Recent Development
Table 99. Sangamo BioSciences Company Details
Table 100. Sangamo BioSciences Business Overview
Table 101. Sangamo BioSciences Product
Table 102. Sangamo BioSciences Revenue in Pompe Disease Treatment Business (2015-2020) (Million US$)
Table 103. Sangamo BioSciences Recent Development
Table 104. Valerion Therapeutics Company Details
Table 105. Valerion Therapeutics Business Overview
Table 106. Valerion Therapeutics Product
Table 107. Valerion Therapeutics Revenue in Pompe Disease Treatment Business (2015-2020) (Million US$)
Table 108. Valerion Therapeutics Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pompe Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Infantile-Onset Pompe Disease Features
Figure 3. Adult-Onset Pompe Disease Features
Figure 4. Global Pompe Disease Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Medical Center Case Studies
Figure 7. Other Case Studies
Figure 8. Pompe Disease Treatment Report Years Considered
Figure 9. Global Pompe Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Pompe Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Pompe Disease Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Pompe Disease Treatment Market Share by Players in 2019
Figure 14. Global Top Pompe Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pompe Disease Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Pompe Disease Treatment Revenue in 2019
Figure 16. North America Pompe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Pompe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Pompe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Pompe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Pompe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Pompe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Pompe Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…
- メニエール病治療の世界市場（～2026年） Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…
- レイノー病治療の世界市場（～2026年） Market Analysis and Insights: Global Raynauds Disease Treatment Market The global Raynauds Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Raynauds Disease Treatment Scope and Market Size Raynauds Dis…